← Back to patent-cliff list
磷酸替诺福韦二吡呋酯
Tier C — Watch / tradeTenofovir disoproxil phosphate
韩美药品株式会社
Originator
2017
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：RT
Brand：Tefovir
Indications (approved)：乙型肝炎
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Tenofovir disoproxil phosphate?
Approved indications include: 乙型肝炎.
When does the Tenofovir disoproxil phosphate patent expire?
No public expiry year is available for Tenofovir disoproxil phosphate yet; this page updates once verified.
How do I get a quote for Tenofovir disoproxil phosphate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25